Renflexis and Urticaria aggravated - a phase IV clinical study of FDA data

Summary:

Urticaria aggravated is reported as a side effect among people who take Renflexis (infliximab-abda), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Prednisone, and have Ulcerative colitis.

The phase IV clinical study analyzes which people have Urticaria aggravated when taking Renflexis. It is created by eHealthMe based on reports of 1,311 people who have side effects when taking Renflexis from the FDA, and is updated regularly.

What is Renflexis?

Renflexis has active ingredients of infliximab-abda. eHealthMe is studying from 1,316 Renflexis users. Check the latest studies of Renflexis.

What is Urticaria aggravated?

Urticaria aggravated (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,058 drugs and 720 conditions by eHealthMe. Check the latest studies of Urticaria aggravated.

On Jul, 26, 2026

1,311 people reported to have side effects when taking Renflexis.
Among them, 37 people (2.82%) have Urticaria aggravated.

Could Renflexis cause Urticaria aggravated?

Among these 37 people:

How long have people been on Renflexis when they have Urticaria aggravated? *

What is the gender of people who have Urticaria aggravated when taking Renflexis? *

female: 68.57 %
male: 31.43 %

What is the age of people who have Urticaria aggravated when taking Renflexis? *

What are other drugs people take besides Renflexis? *

What are other side effects people have besides Urticaria aggravated? *

Itching: 13 people, 35.14%
Rashes (redness): 8 people, 21.62%
Headache (pain in head): 6 people, 16.22%
Chest Pain: 4 people, 10.81%
Skin Blushing/flushing (a sudden reddening of the face, neck): 3 people, 8.11%
Hypersensitivity: 3 people, 8.11%
Fatigue (feeling of tiredness): 3 people, 8.11%
Ill-Defined Disorder: 3 people, 8.11%
Nausea (feeling of having an urge to vomit): 3 people, 8.11%
Pain: 3 people, 8.11%

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 12 people, 32.43%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 8 people, 21.62%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 8.11%
Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 8.11%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.41%
Pain: 1 person, 2.70%
Headache (pain in head): 1 person, 2.70%
Burning Sensation: 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Renflexis and have Urticaria aggravated?

- Check whether Urticaria aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Renflexis:

Renflexis (1,316 reports)

Browse all side effects of Renflexis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urticaria aggravated:

Urticaria aggravated (2,058 drugs)

Browse all the conditions that are associated with Urticaria aggravated:

Urticaria aggravated (720 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab-abda (the active ingredients of Renflexis) and Renflexis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.